Skip to main content

SATURNA CAPITAL CORP

Position in LLY — ELI LILLY & Co

CIK 1316617 BELLINGHAM, WA

Position in LLY

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$510,568,006
-$92,699,369 QoQ
Shares Held
555,104
-1.1% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
7.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98.7813094483196.ToString("F0")% Shared 0.ToString("F0")% None 1.2186905516804059.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

SATURNA CAPITAL CORP holds $1,020,494,047 across 8 Drug Manufacturers - General names. LLY ranks #1 (50.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
555,104 $510,568,006

All Filings in LLY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $510,568,006 555,104
2025-12-31 $603,267,375 561,346
2025-09-30 $449,796,130 589,510
2025-06-30 $462,716,535 593,584
2025-03-31 $496,170,387 600,756
2024-12-31 $485,651,304 629,082
2024-09-30 $575,339,181 649,411
2024-06-30 $618,282,191 682,898
2024-03-31 $538,822,097 692,609
2023-12-31 $414,634,493 711,306
2023-09-30 $408,343,951 760,233
2023-06-30 $373,152,378 795,668
2023-03-31 $273,643,237 796,818
2022-12-31 $298,138,747 814,943
2022-09-30 $263,730,727 815,620
2022-06-30 $264,453,336 815,635
2022-03-31 $263,570,652 920,385
2021-12-31 $254,214,933 920,335
2021-09-30 $212,636,008 920,303
2021-06-30 $211,109,741 919,788
2021-03-31 $171,834,794 919,788
2020-12-31 $155,526,628 921,148
2020-09-30 $136,340,185 921,093
2020-06-30 $151,227,511 921,108
2020-03-31 $127,776,101 921,108